Product Image

Fish Oil 1400 mg

Nature's Bounty
4.7
★ ★ ★ ★ ★
(461 ratings)
EPA (Eicosapentaenoic Acid) 647 mg
Omega-3 980 mg
Fish Oil 1400 mg
DHA 253 mg
Product Image
Score84
A concentrated one-softgel dose provides strong EPA and useful DHA at good active efficiency. Ethyl ester form and limited sourcing and quality-control details are the trade-offs.
How scoring works
Quantity:39 Softgel(s) • (39 servings)
Goals:
Cardiovascular Support
Heart Health
Anti-Inflammatory Support
Skin Health
Mental Focus

Score 84

A concentrated one-softgel dose provides strong EPA and useful DHA at good active efficiency. Ethyl ester form and limited sourcing and quality-control details are the trade-offs.
How scoring works
$10.84($0.27 per serving)
iHerb
$ 10.84
Report prices

Analysis

One softgel delivers 647 mg of EPA and 253 mg of DHA within 980 mg of total omega-3 ethyl esters. The EPA-led balance provides useful depth while retaining a moderate DHA contribution.

High concentration and one-softgel dosing make the product efficient and convenient. Ethyl ester form is clearly disclosed, but fish species, oxidation protection, and independent purity verification are not.

The formula fits adults who want strong EPA delivery without multiple capsules. Taking an ethyl ester oil with food is a practical consideration, and DHA-focused users may prefer a different balance.

Who is it for
  • Adults seeking strong EPA delivery
  • Users who prefer one softgel
  • People comfortable with ethyl ester fish oil
Best for
  • EPA-forward cardiovascular support
  • Inflammatory pathway support
  • Compact high-active dosing

Pros

  • Provides 647 mg of EPA
  • Provides 253 mg of DHA
  • High omega-3 concentration
  • One-softgel serving
  • Ethyl ester form is disclosed

Cons

  • Ethyl ester form is less preferred by some users
  • Fish species is not named
  • No antioxidant protection
  • Independent purity verification is not supplied
  • Short package supply

Warnings

  • Contains fish oil and is not suitable for people with a fish allergy
  • Fish oil may cause fishy aftertaste, reflux, or digestive discomfort in sensitive users
  • The substantial EPA and DHA amount may be relevant for people using anticoagulant or antiplatelet medicines

Nutrient quality

88 Highest impact

Concentrated fish oil in the explicitly disclosed ethyl-ester form gives the formula reasonable ingredient quality. The disclosed amounts are meaningful and the ingredient selection stays focused.

Ingredient transparency

85 Highest impact

The meaningful actives and their amounts are clearly identified. Serving guidance and the complete inactive-ingredient list are not fully supplied.

Customer satisfaction

68 High impact

The aggregate rating is strong and supported by useful review volume. No review excerpts are supplied to assess repeated complaints or purpose-specific experiences.

Value for money

93 Highest impact

Formula quality provides fair value for the category. The effective serving and focused ingredient list compare favorably with similar options.

Report analysis

Goals

Cardiovascular Support
Impact
Highest effect
A+ Goal FitA+ Strength of SupportB CoverageA+ Formula Quality
Fish Oil · 1400 mg

EPA at 647 mg and DHA at 253 mg provide direct, clearly quantified omega-3 support for cardiovascular health. Human evidence is robust for triglyceride management and broader cardiometabolic effects of EPA and DHA.

The ethyl-ester form is transparent and concentrated, though it may absorb better when taken with food. People using anticoagulant or antiplatelet medicines should review this concentrated fish oil with a clinician because omega-3s can add to bleeding risk.

Study evidence
Fish Oil Supportive 185 studies
Heart Health
Impact
Highest effect
A+ Goal FitA+ Strength of SupportB CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 647 mg

EPA at 647 mg and DHA at 253 mg provide direct, clearly quantified omega-3 support for cardiovascular health. Human evidence is robust for triglyceride management and broader cardiometabolic effects of EPA and DHA.

The ethyl-ester form is transparent and concentrated, though it may absorb better when taken with food. People using anticoagulant or antiplatelet medicines should review this concentrated fish oil with a clinician because omega-3s can add to bleeding risk.

Study evidence
Anti-Inflammatory Support
Impact
Highest effect
A Goal FitB- Strength of SupportB+ CoverageA+ Formula Quality
Fish Oil · 1400 mg

EPA and DHA provide direct precursors for inflammation-resolving lipid mediators. Human evidence strongly supports their effects on triglycerides and several inflammatory markers.

The active fatty-acid amount is meaningful, but the ethyl-ester form is less efficiently absorbed. Fish source, purification, independent testing, and antioxidant protection are not disclosed.

Study evidence
Fish Oil Supportive 68 studies
Skin Health
Impact
High effect
B Goal FitB- Strength of SupportC+ CoverageB+ Formula Quality
Omega-3 · NP

EPA and DHA support skin-barrier lipids and inflammatory balance. Human evidence supports omega-3 intake for some dryness and photo-response outcomes, though results vary.

The combined EPA and DHA amount is meaningful for daily support. Amounts are clear, but the ethyl ester form and absent antioxidant or purity verification lower quality confidence.

Study evidence
Omega-3 Supportive 35 studies
Mental Focus
Impact
High effect
D+ Goal FitB- Strength of SupportC CoverageA+ Formula Quality

The EPA-centered fish oil may support the broader brain environment, but it is not an acute focus supplement. Direct evidence for improved attention is less consistent than evidence for general omega-three nutrition and mood support.

EPA and DHA amounts are substantial and clearly disclosed in one softgel. The ethyl-ester form is less absorbable than triglyceride forms, and no antioxidant protection or independent purity testing is provided.

Study evidence

Ingredients

IngredientAmount per serving
Calories
15 Calorie(s)
Total Fat
1.5 Gram(s)
Polyunsaturated Fat
1.5 Gram(s)
Cholesterol
5 mg
Fish Oil
1400 mg
Total Omega-3 Fatty Acids Ethyl Esters
980 mg
Eicosapentaenoic Acid
647 mg
Docosahexaenoic Acid
253 mg
Other Omega-3 Fatty Acids
0 NP
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
D Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value

The label explicitly uses the less-absorbable ethyl-ester form, but EPA is highly concentrated within the total omega-three content. The dose and strongly EPA-centered ratio are well suited to this collection. Cost efficiency is excellent, though no antioxidant protection or independent purity verification is supplied.

Omega-3 · 980 mg OverallScore62
D- Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyA+ Value

The label clearly supplies 647 mg EPA and 253 mg DHA in an ethyl ester concentrate. Active concentration is strong and the low serving cost yields excellent value per useful gram. Generic fish sourcing, missing antioxidant protection, and absent independent purity verification limit quality assurance.

Fish Oil · 1400 mg OverallScore57
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyA+ Value

The label clearly uses the less efficiently absorbed ethyl ester form, but it still provides a useful and highly concentrated EPA and DHA amount. Its cost per active amount is excellent. Generic fish sourcing and no stated purification, independent testing, or antioxidant protection limit quality confidence.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  2. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  3. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  4. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  5. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  6. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  7. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  8. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  9. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  10. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  11. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  12. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  13. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  14. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  15. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  16. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  17. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  18. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  19. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  20. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  21. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  22. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsSkin Health forOmega-3
  23. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  24. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3